Healthcare -
Biotechnology - NASDAQ - US
$ 0.53
-3.46 %
$ 2.51 M
Market Cap
-0.11
P/E
PCSA - STOCK-BASED COMPENSATION
Stock-based Compensation PCSA - Processa Pharmaceuticals, Inc.
1.06 M
LAST VALUE
-44.22%
2 YEAR CAGR
70.28%
5 YEAR CAGR
17.24%
10 YEAR CAGR